NCAM: A Protein Vital To Neural Development and Function (G4684)

Target Name: NCAM1

NCBI ID: G4684

NCAM1

NCAM: A Protein Vital To Neural Development and Function

Neural cell adhesion molecule (NCAM), also known as N-cadherin, is a protein that plays a vital role in the development and maintenance of neural tissues. It is a transmembrane protein that is expressed in a wide range of neural tissues, including brain, spinal cord, and peripheral nerves. NCAM is involved in many different processes in neural development, including cell adhesion, migration, and differentiation.

NCAM is a protein that consists of four transmembrane segments. The first segment contains a catalytic domain that is involved in the formation of the protein. The second segment contains a transmembrane domain that is responsible for the stability and localization of the protein. The third segment contains a cytoplasmic domain that is involved in the interaction with other cellular structures. The fourth segment contains a C-terminal domain that is involved in the formation of aggregates and is also involved in the interaction with other proteins.

NCAM is involved in many different processes in neural development and function. One of its main functions is to promote the adhesion of neurons to the developing neural stem cell. NCAM helps to hold the cell adhering to the substrate and also helps to regulate the level of adhesion molecules on the cell surface. This is important for the proper development and function of the neural stem cell, and is also important for the formation of the neural tissue.

NCAM is also involved in the regulation of neuronal migration. During the development of the neural tissue, NCAM helps to regulate the movement of neurons to their final destination. This is important for the formation of the neural network and the proper functioning of the neural system.

NCAM is also involved in the regulation of neural differentiation. During the development of the neural tissue, NCAM helps to regulate the differentiation of stem cells into different types of neurons. This is important for the formation of the neural network and the proper functioning of the neural system.

NCAM is a protein that is involved in many different processes in neural development and function. As a result, it is a potential drug target for the treatment of a wide range of neural system disorders. Researchers are currently studying the potential uses of NCAM as a drug target, including the treatment of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

In addition to its involvement in neural development and function, NCAM is also a potential biomarker for the diagnosis of some neural system disorders. The levels of NCAM have been shown to be altered in a number of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. This suggests that NCAM may be a useful biomarker for the diagnosis and treatment of these disorders.

Overall, NCAM is a protein that plays a vital role in the development and maintenance of neural tissues. It is involved in many different processes in neural development and function, including cell adhesion, migration, and differentiation. As a result, it is a potential drug target and biomarker for the treatment of a wide range of neural system disorders. Further research is needed to fully understand the role of NCAM in neural development and function, and to develop effective treatments for the disorders that are caused by its dysfunction.

Protein Name: Neural Cell Adhesion Molecule 1

Functions: This protein is a cell adhesion molecule involved in neuron-neuron adhesion, neurite fasciculation, outgrowth of neurites, etc

The "NCAM1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NCAM1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets